TAC briefing paper debunks common pharma myths

Source: Fix the patent laws

Dear All

In the context of the public comment period on the draft national IP
policy, the Treatment Action Campaign has produced a briefing paper
responding to various myths concerning pharmaceutical R&D and the
economics of drug development.

The paper can be found here:

Hopefully this paper will contribute some nuance and a much-needed
evidence base to the debate around the role of patents in access to
medicines in a developing country like ours.

For updates on the TAC/MSF ‘Fix the patent laws’ campaign see


This entry was posted in Generics, Investment treaties, IP Rights, Patents, TRIPS, WTO and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s